88 related articles for article (PubMed ID: 19450999)
1. What is the adequacy of biopsies for prostate sampling?
Dogan HS; Aytac B; Kordan Y; Gasanov F; Yavascaoglu İ
Urol Oncol; 2011; 29(3):280-3. PubMed ID: 19450999
[TBL] [Abstract][Full Text] [Related]
2. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
3. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
4. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
[TBL] [Abstract][Full Text] [Related]
5. Prostate biopsy: who, how and when. An update.
Djavan B; Milani S; Remzi M
Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
[TBL] [Abstract][Full Text] [Related]
6. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy.
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2004 Jun; 11(6):402-6. PubMed ID: 15157210
[TBL] [Abstract][Full Text] [Related]
7. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
[TBL] [Abstract][Full Text] [Related]
8. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M
J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
Stewart CS; Leibovich BC; Weaver AL; Lieber MM
J Urol; 2001 Jul; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
[TBL] [Abstract][Full Text] [Related]
10. Repeat prostate needle biopsy: who needs it?
Ellis WJ; Brawer MK
J Urol; 1995 May; 153(5):1496-8. PubMed ID: 7536254
[TBL] [Abstract][Full Text] [Related]
11. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection.
Eskicorapci SY; Guliyev F; Akdogan B; Dogan HS; Ergen A; Ozen H
J Urol; 2005 May; 173(5):1536-40. PubMed ID: 15821481
[TBL] [Abstract][Full Text] [Related]
12. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
Dai B; Ye DW; Kong YY; Shen YJ; Wang BH
Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
[TBL] [Abstract][Full Text] [Related]
13. [Biopsy technique and biopsy schemes for a first series of prostatic biopsies].
Villers A; Mouton D; Rébillard X; Chautard D; Ruffion A; Staerman F; Cornud F
Prog Urol; 2004 Apr; 14(2):144-53. PubMed ID: 15217126
[TBL] [Abstract][Full Text] [Related]
14. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
[TBL] [Abstract][Full Text] [Related]
15. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
Terakawa T; Miyake H; Kanomata N; Kumano M; Takenaka A; Fujisawao M
Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
[TBL] [Abstract][Full Text] [Related]
16. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model.
Abdel-Khalek M; El-Baz M; Ibrahiem el-H
BJU Int; 2004 Sep; 94(4):528-33. PubMed ID: 15329106
[TBL] [Abstract][Full Text] [Related]
17. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
18. [Repeat prostate biopsy in patients with previous negative biopsies].
Nagata M; Sato T; Un-no T; Nagae H; Mugiya S; Takayama T; Suzuki K; Fujita K
Hinyokika Kiyo; 2002 Oct; 48(10):589-92. PubMed ID: 12491609
[TBL] [Abstract][Full Text] [Related]
19. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
Philip J; Hanchanale V; Foster CS; Javlé P
BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
[TBL] [Abstract][Full Text] [Related]
20. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate.
Shuman BA; Cohen JK; Miller RJ; Rooker GM; Olson PR
J Urol; 1997 Feb; 157(2):552-5. PubMed ID: 8996354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
